{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:30:50Z","timestamp":1787797850212,"version":"build-2784847793"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australian Commonwealth Department of Health, Medical Research Future Fund","award":["MRFAR000079"],"award-info":[{"award-number":["MRFAR000079"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["PRC3 - 2015744"],"award-info":[{"award-number":["PRC3 - 2015744"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many people experience withdrawal symptoms when they attempt to stop antidepressants. Withdrawal symptoms are readily misconstrued for relapse or ongoing need for medication, contributing to long-term use (&gt;\u200912\u00a0months). Long-term antidepressant use is increasing internationally yet is not recommended for most people. Long-term use is associated with adverse effects including weight gain, sexual dysfunction, lethargy, emotional numbing and increased risk of falls and fractures. This study aims to determine the effectiveness of two multi-strategy interventions (RELEASE and RELEASE+) in supporting the safe cessation of long-term antidepressants, estimate cost-effectiveness, and evaluate implementation strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1. Setting: primary care general practices in southeast Queensland, Australia. Population: adults 18\u00a0years or older taking antidepressants for longer than 1\u00a0year. Practices will be randomised on a 1.5:1:1 ratio of Usual care:RELEASE:RELEASE+. Intervention: RELEASE for patients includes evidence-based information and resources and an invitation to medication review; RELEASE for GPs includes education, training and printable resources via practice management software. RELEASE+ includes additional internet support for patients and prescribing support including audit and feedback for GPs. Outcome measures: the primary outcome is antidepressant use at 12\u00a0months self-reported by patients. Cessation is defined as 0\u00a0mg antidepressant maintained for at least 2\u00a0weeks. Secondary outcomes: at 6 and 12\u00a0months are health-related quality of life, antidepressant side effects, well-being, withdrawal symptoms, emotional numbing, beliefs about antidepressants, depressive symptoms, and anxiety symptoms; and at 12\u00a0months 75% reduction in antidepressant dose; aggregated practice level antidepressant prescribing, and health service utilisation for costs. Sample size: 653 patients from 28 practices. A concurrent evaluation of implementation will be through mixed methods including interviews with up to 40 patients and primary care general practitioners, brief e-surveys, and study administrative data to assess implementation outcomes (adoption and fidelity).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The RELEASE study will develop new knowledge applicable internationally on the effectiveness, cost-effectiveness, and implementation of two multi-strategy interventions in supporting the safe cessation of long-term antidepressants to improve primary health care and outcomes for patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ANZCTR, ACTRN12622001379707p. Registered on 27 October 2022.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07646-w","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:01:50Z","timestamp":1695870110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practice"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2580-9362","authenticated-orcid":false,"given":"Katharine A.","family":"Wallis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Donald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Moncrieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Thrift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MaryAnne","family":"Cleetus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idin","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Zwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"7646_CR1","doi-asserted-by":"publisher","unstructured":"OECD. Pharmaceutical consumption. In: Health at a glance 2021: OECD indicators. OECD; 2021. https:\/\/doi.org\/10.1787\/ae3016b9-en.","DOI":"10.1787\/ae3016b9-en"},{"issue":"12","key":"7646_CR2","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/0004867415621392","volume":"50","author":"SR Kjosavik","year":"2016","unstructured":"Kjosavik SR, Gillam MH, Roughead EE. Average duration of treatment with antidepressants among concession card holders in Australia. Aust N Z J Psychiatry. 2016;50(12):1180\u20135.","journal-title":"Aust N Z J Psychiatry"},{"issue":"10","key":"7646_CR3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1177\/0004867417721018","volume":"51","author":"J Brett","year":"2017","unstructured":"Brett J, Karanges EA, Daniels B, Buckley NA, Schneider C, Nassir A, et al. Psychotropic medication use in Australia, 2007 to 2015: changes in annual incidence, prevalence and treatment exposure. Aust N Z J Psychiatry. 2017;51(10):990\u20139.","journal-title":"Aust N Z J Psychiatry"},{"key":"7646_CR4","unstructured":"Mental Health Online Report: mental health-related prescriptions. Australian Institute of Health and Welfare; 2020. Available from: https:\/\/www.aihw.gov.au\/getmedia\/d574a481-eda0-474a-88ea-7db003ab412b\/Mental-health-related-prescriptions-2021-22.xlsx.aspx."},{"key":"7646_CR5","doi-asserted-by":"crossref","first-page":"204512532092169","DOI":"10.1177\/2045125320921694","volume":"10","author":"MP Hengartner","year":"2020","unstructured":"Hengartner MP. How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding. Ther Adv Psychopharmacol. 2020;10:2045125320921694.","journal-title":"Ther Adv Psychopharmacol"},{"key":"7646_CR6","unstructured":"Therapeutic Guidelines Limited. Therapeutic guidelines 2023. Available from: www.tg.org.au.\u00a0Accessed 7 May 2023."},{"key":"7646_CR7","unstructured":"Royal College of Psychiatrists. Position statement on antidepressants and depression. 2019. Available from: https:\/\/www.rcpsych.ac.uk\/docs\/default-source\/improving-care\/better-mh-policy\/position-statements\/ps04_19---antidepressants-and-depression.pdf?sfvrsn=ddea9473_5."},{"issue":"1","key":"7646_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","volume":"55","author":"GS Malhi","year":"2021","unstructured":"Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2021;55(1):7\u2013117.","journal-title":"Aust N Z J Psychiatry"},{"issue":"7","key":"7646_CR9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5694\/mja2.50522","volume":"212","author":"J Rothmore","year":"2020","unstructured":"Rothmore J. Antidepressant-induced sexual dysfunction. Med J Aust. 2020;212(7):329\u201334.","journal-title":"Med J Aust"},{"issue":"1","key":"7646_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.sxmr.2017.07.002","volume":"6","author":"A Bala","year":"2018","unstructured":"Bala A, Nguyen HMT, Hellstrom WJG. Post-SSRI sexual dysfunction: a literature review. Sex Med Rev. 2018;6(1):29\u201334.","journal-title":"Sex Med Rev"},{"issue":"3","key":"7646_CR11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1192\/bjp.bp.108.051110","volume":"195","author":"J Price","year":"2009","unstructured":"Price J, Cole V, Goodwin GM. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br J Psychiatry. 2009;195(3):211\u20137.","journal-title":"Br J Psychiatry"},{"key":"7646_CR12","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/PPA.S110632","volume":"10","author":"C Cartwright","year":"2016","unstructured":"Cartwright C, Gibson K, Read J, Cowan O, Dehar T. Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Prefer Adherence. 2016;10:1401\u20137.","journal-title":"Patient Prefer Adherence"},{"key":"7646_CR13","doi-asserted-by":"crossref","first-page":"d4551","DOI":"10.1136\/bmj.d4551","volume":"343","author":"C Coupland","year":"2011","unstructured":"Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551.","journal-title":"BMJ"},{"key":"7646_CR14","doi-asserted-by":"publisher","unstructured":"Horowitz MA, Framer A, Hengartner MP, S\u00f8rensen A, Taylor D. Estimating risk of antidepressant withdrawal from a review of published data. CNS Drugs. 2023;37:143\u201357. https:\/\/doi.org\/10.1007\/s40263-022-00960-y.","DOI":"10.1007\/s40263-022-00960-y"},{"key":"7646_CR15","doi-asserted-by":"crossref","first-page":"204512532098057","DOI":"10.1177\/2045125320980573","volume":"10","author":"MP Hengartner","year":"2020","unstructured":"Hengartner MP, Schulthess L, Sorensen A, Framer A. Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. Ther Adv Psychopharmacol. 2020;10:2045125320980573.","journal-title":"Ther Adv Psychopharmacol"},{"key":"7646_CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addbeh.2018.08.027","volume":"97","author":"J Davies","year":"2019","unstructured":"Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav. 2019;97:111\u201321.","journal-title":"Addict Behav"},{"issue":"5","key":"7646_CR17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000506868","volume":"89","author":"F Cosci","year":"2020","unstructured":"Cosci F, Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom. 2020;89(5):283\u2013306.","journal-title":"Psychother Psychosom"},{"key":"7646_CR18","doi-asserted-by":"crossref","unstructured":"Horowitz MA, Taylor D. Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies. BJPsych Adv.\u00a02022;28(5):297\u2013311.","DOI":"10.1192\/bja.2021.62"},{"key":"7646_CR19","doi-asserted-by":"crossref","first-page":"204512532098117","DOI":"10.1177\/2045125320981174","volume":"11","author":"E White","year":"2021","unstructured":"White E, Read J, Julo S. The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? Ther Adv Psychopharmacol. 2021;11:2045125320981174.","journal-title":"Ther Adv Psychopharmacol"},{"key":"7646_CR20","unstructured":"Productivity Commission. Mental health, inquiry report. Canberra; 2020. Available from: https:\/\/www.pc.gov.au\/inquiries\/completed\/mental-health\/report."},{"issue":"2","key":"7646_CR21","first-page":"105","volume":"5","author":"G Cruickshank","year":"2008","unstructured":"Cruickshank G, Macgillivray S, Bruce D, Mather A, Matthews K, Williams B. Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care. Ment Health Fam Med. 2008;5(2):105\u20139.","journal-title":"Ment Health Fam Med"},{"key":"7646_CR22","doi-asserted-by":"crossref","first-page":"204512532096718","DOI":"10.1177\/2045125320967183","volume":"10","author":"A Guy","year":"2020","unstructured":"Guy A, Brown M, Lewis S, Horowitz M. The \u2018patient voice\u2019: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition. Ther Adv Psychopharmacol. 2020;10:2045125320967183.","journal-title":"Ther Adv Psychopharmacol"},{"key":"7646_CR23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpsychires.2023.03.013","volume":"161","author":"J Read","year":"2023","unstructured":"Read J, Moncrieff J, Horowitz MA. Designing withdrawal support services for antidepressant users: patients\u2019 views on existing services and what they really need. J Psychiatr Res. 2023;161:298\u2013306.","journal-title":"J Psychiatr Res"},{"key":"7646_CR24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jad.2018.10.107","volume":"245","author":"E Maund","year":"2019","unstructured":"Maund E, Dewar-Haggart R, Williams S, Bowers H, Geraghty AWA, Leydon G, et al. Barriers and facilitators to discontinuing antidepressant use: a systematic review and thematic synthesis. J Affect Disord. 2019;245:38\u201362.","journal-title":"J Affect Disord"},{"issue":"6","key":"7646_CR25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2215-0366(19)30032-X","volume":"6","author":"MA Horowitz","year":"2019","unstructured":"Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019;6(6):538\u201346.","journal-title":"Lancet Psychiatry"},{"key":"7646_CR26","doi-asserted-by":"crossref","first-page":"204512532199127","DOI":"10.1177\/2045125321991274","volume":"11","author":"A Framer","year":"2021","unstructured":"Framer A. What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Ther Adv Psychopharmacol. 2021;11:2045125321991274.","journal-title":"Ther Adv Psychopharmacol"},{"key":"7646_CR27","doi-asserted-by":"crossref","first-page":"204512532110393","DOI":"10.1177\/20451253211039327","volume":"11","author":"PC Groot","year":"2021","unstructured":"Groot PC, van Os J. Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study. Ther Adv Psychopharmacol. 2021;11:20451253211039330.","journal-title":"Ther Adv Psychopharmacol"},{"key":"7646_CR28","doi-asserted-by":"crossref","first-page":"204512532311715","DOI":"10.1177\/20451253231171518","volume":"13","author":"J van Os","year":"2023","unstructured":"van Os J, Groot PC. Outcomes of hyperbolic tapering of antidepressants. Ther Adv Psychopharmacol. 2023;13:20451253231171520.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"5","key":"7646_CR29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.161.5.826","volume":"161","author":"JH Meyer","year":"2004","unstructured":"Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, et al. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry. 2004;161(5):826\u201335.","journal-title":"Am J Psychiatry"},{"key":"7646_CR30","unstructured":"NICE National Institute for Health and Care Excellence. Adults with depression who want to quit antidepressants should be given support on how to do it safely. 2023. https:\/\/www.nice.org.uk\/news\/nice-draft-quality-standard-depression-adults-update-2023. Accessed 11 Sept 2023."},{"key":"7646_CR31","unstructured":"Royal College of Psychiatrists. Stopping antidepressants. 2020. https:\/\/www.rcpsych.ac.uk\/mental-health\/treatments-and-wellbeing\/stopping-antidepressants. Accessed 7 July 2023."},{"key":"7646_CR32","unstructured":"NICE National Institute for Health and Care Excellence. Depression in adults: treatment and management. 2022. https:\/\/www.nice.org.uk\/guidance\/ng222. Accessed 11 Sept 2023."},{"issue":"4","key":"7646_CR33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0897190012467210","volume":"26","author":"NR Ogle","year":"2013","unstructured":"Ogle NR, Akkerman SR. Guidance for the discontinuation or switching of antidepressant therapies in adults. J Pharm Pract. 2013;26(4):389\u201396.","journal-title":"J Pharm Pract"},{"issue":"12","key":"7646_CR34","doi-asserted-by":"crossref","first-page":"954","DOI":"10.31128\/AJGP-02-21-5828","volume":"50","author":"KA Wallis","year":"2021","unstructured":"Wallis KA, Donald M, Moncrieff J. Antidepressant prescribing in general practice: a call to action. Aust J Gen Pract. 2021;50(12):954\u20136.","journal-title":"Aust J Gen Pract"},{"issue":"4","key":"7646_CR35","doi-asserted-by":"crossref","first-page":"17X101265","DOI":"10.3399\/bjgpopen17X101265","volume":"1","author":"R Eveleigh","year":"2018","unstructured":"Eveleigh R, Muskens E, Lucassen P, Verhaak P, Spijker J, van Weel C, et al. Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care. BJGP Open. 2018;1(4):17X101265.","journal-title":"BJGP Open"},{"issue":"3","key":"7646_CR36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","volume":"50","author":"GM Curran","year":"2012","unstructured":"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217\u201326.","journal-title":"Med Care"},{"issue":"4","key":"7646_CR37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1370\/afm.2094","volume":"15","author":"KA Wallis","year":"2017","unstructured":"Wallis KA, Andrews A, Henderson M. Swimming against the tide: primary care physicians\u2019 views on deprescribing in everyday practice. Ann Fam Med. 2017;15(4):341\u20136.","journal-title":"Ann Fam Med"},{"issue":"2","key":"7646_CR38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1071\/HC17018","volume":"9","author":"KA Wallis","year":"2017","unstructured":"Wallis KA, Tuckey R. Safer Prescribing and Care for the Elderly (SPACE): feasibility of audit and feedback plus practice mail-out to patients with high-risk prescribing. J Prim Health Care. 2017;9(2):145\u201352.","journal-title":"J Prim Health Care"},{"issue":"708","key":"7646_CR39","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.3399\/BJGP.2020.0913","volume":"71","author":"M Donald","year":"2021","unstructured":"Donald M, Partanen R, Sharman L, Lynch J, Dingle GA, Haslam C, et al. Long-term antidepressant use in general practice: a qualitative study of GPs\u2019 views on discontinuation. Br J Gen Pract. 2021;71(708):E508\u201316.","journal-title":"Br J Gen Pract"},{"issue":"3","key":"7646_CR40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0749-3797(01)00350-6","volume":"21","author":"RE Glasgow","year":"2001","unstructured":"Glasgow RE, Eakin EG, Fisher EB, Bacak SJ, Brownson RC. Physician advice and support for physical activity: results from a national survey. Am J Prev Med. 2001;21(3):189\u201396.","journal-title":"Am J Prev Med"},{"issue":"3","key":"7646_CR41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/heapro\/dal017","volume":"21","author":"RE Glasgow","year":"2006","unstructured":"Glasgow RE, Emont S, Miller DC. Assessing delivery of the five \u2018As\u2019 for patient-centered counseling. Health Promot Int. 2006;21(3):245\u201355.","journal-title":"Health Promot Int"},{"issue":"3","key":"7646_CR42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware","year":"1996","unstructured":"Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"issue":"2","key":"7646_CR43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0269881113517957","volume":"28","author":"K Hodgson","year":"2014","unstructured":"Hodgson K, Uher R, Crawford AA, Lewis G, O\u2019Donovan MC, Keers R, et al. Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. J Psychopharmacol. 2014;28(2):142\u201350.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"7646_CR44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1192\/bjp.bp.108.061960","volume":"195","author":"R Uher","year":"2009","unstructured":"Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W, et al. Adverse reactions to antidepressants. Br J Psychiatry. 2009;195(3):202\u201310.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"7646_CR45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1477-7525-10-156","volume":"10","author":"H Maheswaran","year":"2012","unstructured":"Maheswaran H, Weich S, Powell J, Stewart-Brown S. Evaluating the responsiveness of the Warwick Edinburgh Mental Well-Being Scale (WEMWBS): group and individual level analysis. Health Qual Life Outcomes. 2012;10(1):156.","journal-title":"Health Qual Life Outcomes"},{"key":"7646_CR46","unstructured":"Moncrieff J, Read J, Horowitz M. Severity of antidepressant withdrawal effects versus symptoms of underlying conditions. 2023; (in preparation)."},{"key":"7646_CR47","unstructured":"Horowitz M, Moncrieff J. Rapid response: antidepressant discontinuation trial misleading as it likely mis-interprets withdrawal effects as relapse.BMJ Rapid Response. 2021. https:\/\/www.bmj.com\/content\/374\/bmj.n2403\/rr-4."},{"issue":"10","key":"7646_CR48","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/NMD.0b013e318156816f","volume":"195","author":"SM Orsillo","year":"2007","unstructured":"Orsillo SM, Theodore-Oklota C, Luterek JA, Plumb J. The development and psychometric evaluation of the emotional reactivity and numbing scale. J Nerv Ment Dis. 2007;195(10):830\u20136.","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"7646_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","volume":"14","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1\u201324.","journal-title":"Psychol Health"},{"issue":"9","key":"7646_CR50","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"541","key":"7646_CR51","first-page":"650","volume":"57","author":"S Gilbody","year":"2007","unstructured":"Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ\u20139 and CORE\u2013OM. Br J Gen Pract. 2007;57(541):650\u20132.","journal-title":"Br J Gen Pract"},{"issue":"10","key":"7646_CR52","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"5","key":"7646_CR53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","volume":"146","author":"K Kroenke","year":"2007","unstructured":"Kroenke K, Spitzer RL, Williams JBW, Monahan PO, L\u00f6we B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317\u201325.","journal-title":"Ann Intern Med"},{"issue":"1","key":"7646_CR54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50.","journal-title":"Implement Sci"},{"issue":"11","key":"7646_CR55","doi-asserted-by":"crossref","first-page":"e039053","DOI":"10.1136\/bmjopen-2020-039053","volume":"10","author":"MJ Huijbers","year":"2020","unstructured":"Huijbers MJ, Wentink C, Simons E, Spijker J, Speckens A. Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers. BMJ Open. 2020;10(11):e039053.","journal-title":"BMJ Open"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07646-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07646-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07646-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:31:56Z","timestamp":1700285516000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07646-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7646"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07646-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3186495\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been granted ethical approval by The University of Queensland Human Research Ethics Committee (2022\/HE001667) on 18 Oct 2022 for 3\u00a0years. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"The participant information and consent forms are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"MAH declares being the founder of Outro Health, a digital clinic aimed to help people safely stop unnecessary antidepressants in Canada. Honoraria from NHS Trusts, King\u2019s College London and the University of Washington for lectures on antidepressant withdrawal.JM declares National Institute of Health Research funded grants, Modest royalties on authored and edited books, Lecture fees received from Alberta Psychiatric Association, British Psychological Association, Universite de Sherbrooke, Case Western Reserve University, University of Basal, Co-chair person Critical Psychiatry Network, Unpaid board member of non-profit Council for Evidence-based psychiatry.The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"615"}}